Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National, Multi-Center, Open-Label, Three-Arm, Phase II Study to Investigate the Effect of Montelukast Between Emergency Room Visits and Hospitalizations in COVID-19 Pneumonia in Comparison With Standard Treatment

NCT04718285 is registered in ClinicalTrials.gov with Bahçeşehir University as lead sponsor.

NCT NCT04718285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04718285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National, Multi-Center, Open-Label, Three-Arm, Phase II Study to Investigate the Effect of Montelukast Between Emergency Room Visits and Hospitalizations in COVID-19 Pneumonia in Comparison With Standard Treatment
Lead sponsor
Bahçeşehir University
Phase
Phase 2
Overall status
Unknown status
Start date
May 15, 2021
Completion date
June 1, 2022
Enrollment
380 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2